Skip to search formSkip to main contentSkip to account menu

surotomycin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

CB-183,315

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Therapie akuter und rekurrenter Clostridium-difficile-Infektionen
ZusammenfassungWeltweit liegt die Inzidenz von Clostridium-difficile-Infektionen (CDI) auf einem hohen Niveau. Auch in… 
2018
2018
Sub‐lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro
Purpose. Clostridium difficile is an anaerobic spore‐forming bacterial pathogen that causes a spectrum of illness severity… 
Review
2018
Review
2018
Sa1858 - Surotomycin (A Novel Antibiotic) vs Vancomycin for Clostridium Difficile Infection: A Systematic Review and Meta Analysis
2017
2017
Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers
Surotomycin, a novel, orally administered, cyclic, lipopeptide antibacterial in development for the treatment of Clostridium… 
2016
2016
Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes
ABSTRACT Surotomycin is a cyclic lipopeptide in development for Clostridium difficile-associated diarrhea. This study aimed to… 
2015
2015
Mode of Action and Bactericidal Properties of Surotomycin against Growing and Nongrowing Clostridium difficile
ABSTRACT Surotomycin (CB-183,315), a cyclic lipopeptide, is in phase 3 clinical development for the treatment of Clostridium… 
2015
2015
Neue Antibiotika auf dem Markt und in Entwicklung
ZusammenfassungNach Jahren der Stagnation sind inzwischen wieder zahlreiche Neuentwicklungen im Bereich der antibakteriellen… 
2015
2015
Discovery and development of Surotomycin
Review
2015
Review
2015
[New antibacterial agents on the market and in the pipeline].
After some years of stagnation there have been several new successful developments in the field of antibacterial agents. Most of… 
Review
2013
Review
2013
Therapy of Clostridium difficile infection: perspectives on a changing paradigm
Introduction: Clostridium difficile disease (CDI) have increased in frequency and severity over the past decade and are a leading… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)